RNA Therapeutics
Date: | 16-Feb-15 to 17-Feb-15 |
Location: | Marriott Hotel Regents Park / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
RNA Therapeutics 2015 returns to London on 16th and 17th February, gathering a room full of scientific pioneers and industry experts to identify the latest advancements, best practice and strategies to maximise return on investment.
Hear case study driven presentations from an array of market leaders such as Roche, CRISPR Therapeutics, Leiden University Medical Centre, MiNa Therapeutics and AstraZeneca, discussing CRIPSPR gene editing technologies, hepatic targeting, viral delivery, the patent application process, RNA splicing, plus much more!
KEY SPEAKERS
• Claude Paul Malvy, Professor, Universite Paris Sud - CONFERENCE CHAIR
• Joerg Kaufmann, Chief Scientific Officer, Silence Therapeutics - CONFERENCE CHAIR
• Bo Rode Hansen, VP, Drug Discovery & Alliance, Roche
• Rodger Novak, CEO, CRISPR Therapeutics
• Annemieke Aartsma-Rus, Associate Professor, Leiden University Medical Center
• Nagy Habib, Chairman and Co Founder, MiNa Therapeutics
• David Blakey, Chief Scientist, AstraZeneca
REASONS TO ATTEND
• Take away best practice learning on efficient and targeted efforts to maximise return on investment
• Hear key case studies from leading companies and gain the edge in confronting the challenges of oligonucleotide R&D
• Discover the latest clinical data in RNAi, ASO and miRNA medicine including the latest RNA activation approaches
• Review new conjugate/aptamer/lipid/polymer/nanoparticle delivery systems to enhance the efficacy and bioavailability of compounds
• Update on the state of CRISPR technology for therapy
• Enhance knowledge on intellectual property issues (IP)
Hear case study driven presentations from an array of market leaders such as Roche, CRISPR Therapeutics, Leiden University Medical Centre, MiNa Therapeutics and AstraZeneca, discussing CRIPSPR gene editing technologies, hepatic targeting, viral delivery, the patent application process, RNA splicing, plus much more!
KEY SPEAKERS
• Claude Paul Malvy, Professor, Universite Paris Sud - CONFERENCE CHAIR
• Joerg Kaufmann, Chief Scientific Officer, Silence Therapeutics - CONFERENCE CHAIR
• Bo Rode Hansen, VP, Drug Discovery & Alliance, Roche
• Rodger Novak, CEO, CRISPR Therapeutics
• Annemieke Aartsma-Rus, Associate Professor, Leiden University Medical Center
• Nagy Habib, Chairman and Co Founder, MiNa Therapeutics
• David Blakey, Chief Scientist, AstraZeneca
REASONS TO ATTEND
• Take away best practice learning on efficient and targeted efforts to maximise return on investment
• Hear key case studies from leading companies and gain the edge in confronting the challenges of oligonucleotide R&D
• Discover the latest clinical data in RNAi, ASO and miRNA medicine including the latest RNA activation approaches
• Review new conjugate/aptamer/lipid/polymer/nanoparticle delivery systems to enhance the efficacy and bioavailability of compounds
• Update on the state of CRISPR technology for therapy
• Enhance knowledge on intellectual property issues (IP)
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today